Riskpilot← Back to searchSign inGet full accessATH Medical Oy
OYDissolvedY-tunnus 2785378-3Tuulenpuoli 5Medical specialists activities · NACE 8622Est. 20162 employees
Revenue 2025
EUR 617K
-1% vs 2024
EBITDA margin
59.8%
+5% vs 2024
Equity ratio
99.6%
Financial strength
Net profit 2025
EUR 289K
+7% vs 2024
| Revenue | EUR 617K | -1% |
| EBITDA | EUR 369K | +5% |
| Net profit | EUR 289K | +7% |
| Total assets | EUR 1,7M | +6% |
| Equity | EUR 1,7M | +11% |
| Employees | 2 | — |
Legal name
ATH Medical Oy
Y-tunnus number
2785378-3
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
30. syyskuuta 2016
Share capital
EUR 2 500
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on terveydenhoito- ja lääkäripalveluiden tuottaminen, koulutus- ja konsultointipalvelut, lääke- ja muut terveydenhuoltoalan tutkimustyöt sekä muu laillinen liiketoiminta. Yhtiö voi harjoittaa arvopaperikauppaa sekä ostaa, hallita ja myydä kiinteistöjä.
Address
Tuulenpuoli 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 526 | 510 | 612 | 621 | 617 |
| Staff expenses | −74 | −96 | −89 | −101 | −94 |
| EBITDA | 315 | 284 | 365 | 350 | 369 |
| Depreciation & amort. | −16 | −12 | −9 | −22 | −17 |
| EBIT | 299 | 272 | 356 | 328 | 352 |
| Net financials | 49 | −20 | 5 | 13 | 10 |
| Profit before tax | 348 | 252 | 362 | 341 | 362 |
| Tax | 66 | 58 | 15 | 71 | 73 |
| Net profit | 282 | 194 | 287 | 270 | 289 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 073 | 1 185 | 1 494 | 1 606 | 1 694 |
| Equity | 1 073 | 1 181 | 1 370 | 1 526 | 1 688 |
| Long-term debt | — | 4 | 4 | 4 | 7 |
| Short-term debt | 0 | 0 | 120 | 76 | 0 |
| Total debt | 0 | 4 | 124 | 79 | 7 |
EBITDA margin
59.8%
This company
15.8%
Market median
+278% vs market
20212025
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
20212025
Return on equity
17.1%
This company
18.4%
Market median
+7% vs market
20212025
Net profit margin
46.8%
This company
8.1%
Market median
+478% vs market
20212025
Asset turnover
0.36×
This company
1.12×
Market median
-68% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TK Person with significant control | Person with significant control | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ATH Medical Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Taru Kaarina Hakala | Person with significant control | 0 companies |
| Antti Viljami Hakala | Board of Directors | 0 companies |